Sutherlandia frutescens (L.) R. Br. (Fabaceae) Baguenaudier d’Éthiopie

Itis (Integrated taxonomic information system): Fabaceae of North America Update database (version 2011); (updated for ITIS by the Flora of North America Expertise Network, in connection with an update for USDA PLANTS (2007–2010): http://www.itis.gov/servlet/SingleRpt/SingleRpt

Phillips E, Dyer RA (1989) Revista Sudamer. Bot. 1: 76, fig. 2 (1934). — Lock, Leg. Afr. Check-list: 265

Exotic-plants: http://www.exotic-plants.de/graines/graines-Afrique-du-Sud/Sutherlandia-frutescens.php

Blueskyorganics: http://www.blueskyorganics.co.za/?spa_products=70-olive-leaf-tea-with-30-sutherlandia-cancer-bush

Pousset JL (2004) Plantes médicinales d’Afrique. Comment les reconnaître et les utiliser. Ed. Édisud, La Calade, France

Roberts M (1990) Indigenous healing plants. Southern Book Publishers, Halfway House, Gauteng, South Africa, 55

Fu X, Li XC, Smilie TJ, Khan IA, et al. (2008) Cycloartane glcosides from Sutherlandia frutescens. J Nat Prod 71: 1749–1753

Fu X, Li XC, Avula B, IA Khan IA, et al. (2009) Flavonoid glycosides from Sutherlanida frutescens. Planta Med 75: 34

Gericke N, Albrecht CF, Van Wyk B, et al. (2001) Sutherlandia frutescens. AJMH 13: 9–15

Shaik S, Singh N, Nicholas A (2011) A comparison of the selected secondary metabolites content present in the cancer-bush Lessertia (Sutherlandia) frutescens L. extracts. Afr J Tradit Complement Altern Med 8: 429–434

Tai J, Cheung S, Chan E, Hasman D (2004) In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. J Ethnopharmacol 93: 9–19

Van Wyk BE, Albrecht C (2008) A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J Ethnopharmacol 119: 620–629

Zhang B, Leung WK, Zou Y, Paulsen BS (2014) Immunomodulating polysaccharides from Lessertia frutescens leaves: Isolation, characterization and structure activity relationship. J Ethnopharmacol 152: 340–348

Ojewole JA (2004) Analgesic, anti-inflammatory and hypoglycemic effects of Sutherlandia frutescens R. Br. Variety Incana E. Mey) shoot aqueous extract. Methods Find Exp Clin Pharmacol 26: 409–416

Van Wyk B, Gericke N (2000) People’s plants — a guide to the useful plants in South Africa. Pretoria, Briza

Sivakumar S, Palsamy P, Subramanian SP (2010) Impact of D-pinitol on the attenuation of proinflammatory cytokines, hyperglycemia-mediated oxidative stress and protection of kidney tissue ultrastructure in streptozotocin-induced diabetic rats. Chem Biol Interact 188: 237–245

Capasso R, Izzo AA, Pinto L, et al. (2000) Phytotherapy and quality of herbal medicines. Fitoterapia 71: S58–S65

Ostlund RE, Sherman WR (1996) Pinitol and derivatives thereof for the treatment of metabolic disorders. US Patent 5, 8827, 896

Chadwick WA, Roux S, van de Venter M, et al. (2007) Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet. J Ethnopharmacol 109: 121–127

Narayanan Joshi DD, Mujumdar AM (1987) Pinitol — a new antidiabetic compound from the leaves of Bougainvillea spectabilisf. Current Sci 56: 139–141

Fernandes AC, Cromarty AD, Albrecht C, van Rensburg CE (2004) The antioxidant potential of Sutherlandia frutescens. J Ethnopharmacol 95: 1–5

Ngcobo M, Gqaleni N, Chelule PK, et al. (2012) Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro. Afr J Tradit Complement Altern Med 9: 73–80

Chinkwo KA (2005) Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells. J Ethnopharmacol 98: 163–170

Skerman NB, Joubert AM, Cronjé MJ (2011) The apoptosis inducing effects of Sutherlandia ssp. extracts on an oesophageal cancer cell line. J Ethnopharmacol 137: 1250–1260

Swaffer DS, Ang CY, Desai PB, Rosenthal GA (1994) Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res 54: 6045–6048

Grandi M, Roselli L, Vernay M (2005) Lessertia (Sutherlandia frutescens) et la fatigue en cancérologie. Phytothérapie 3: 110–113

Harnett SM, Oosthuizen V, van de Venter M (2005) Anti-HIV activities of organic and aqueous extract of Sutherlandia frutescens and Lobostemon trigonous. J Ethnopharmacol 96: 113–119

Smith A (1895) A contribution to the South African materia medica, 3rd ed. Lovedale, South Africa

Mills EJ, Foster BC, van Heeswijk RP, et al. (2005) Impact of African herbal medicines on antiretroviral metabolism. AIDS 19:95–97

Seier JV, Mdhuli M, Dhansay MA, et al. (2002) A toxicity study of Sutherlandia leaf powder (Sutherlandia microphylla) consumption. South African Ministry of Health Document

Prete P (1985) Effects of L-canavanine on immune function in normal and autoimmune mice: disordered B-cell function by a dietary amino acid in the immunoregulaion of autoimmune disease. Can J Physiol Pharmacol 63: 843–854

Dalvi S (2003) Sutherlandia for immune support. Positive Health 23–25